WallStSmart

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)vsQuipt Home Medical Corp (QIPT)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Quipt Home Medical Corp generates 1872% more annual revenue ($264.97M vs $13.43M). QIPT leads profitability with a -0.0% profit margin vs -8.5%. QIPT earns a higher WallStSmart Score of 40/100 (D).

HKPD

Avoid

29

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 2/9Altman Z: 3.44

QIPT

Hold

40

out of 100

Grade: D

Growth: 5.3Profit: 2.5Value: 5.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HKPD.

QIPTUndervalued (+8.7%)

Margin of Safety

+8.7%

Fair Value

$3.90

Current Price

$3.65

$0.25 discount

UndervaluedFair: $3.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HKPD3 strengths · Avg: 9.7/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
3.4410/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

QIPT1 strengths · Avg: 8.0/10
Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

HKPD4 concerns · Avg: 2.5/10
Market CapQuality
$5.52M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

Revenue GrowthGrowth
-31.7%2/10

Revenue declined 31.7%

QIPT4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.3%4/10

0.3% revenue growth

Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HKPD

The strongest argument for HKPD centers on Price/Book, Altman Z-Score, Debt/Equity.

Bull Case : QIPT

The strongest argument for QIPT centers on Price/Book.

Bear Case : HKPD

The primary concerns for HKPD are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : QIPT

The primary concerns for QIPT are Revenue Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

QIPT is growing revenue faster at 0.3% — sustainability is the question.

QIPT generates stronger free cash flow (7M), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

QIPT scores higher overall (40/100 vs 29/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Hong Kong Pharma Digital Technology Holdings Limited is a pioneering entity in the biotechnology and digital healthcare sectors, focused on enhancing patient outcomes through innovative pharmaceutical services. By harnessing cutting-edge digital technologies and sophisticated data analytics, the company optimizes drug development and boosts operational efficiencies, positioning itself as a key player in the dynamic healthcare landscape. With a commitment to health technology advancement and strategic collaborations, Hong Kong Pharma is well-equipped to meet the evolving needs of both domestic and international markets while propelling innovation within its extensive service offerings.

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

Want to dig deeper into these stocks?